![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | ~12 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C8H10N2 |
Molar mass | 134.182 g·mol−1 |
3D model ( JSmol) | |
|
Phenylethylidenehydrazine (PEH), also known as 2-phenylethylhydrazone or β-phenylethylidenehydrazine, is a GABA transaminase inhibitor. [1] [2] It is a metabolite of the antidepressant phenelzine and is responsible for its elevation of GABA concentrations. [1] PEH may contribute to phenelzine's anxiolytic effects. [3]
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | ~12 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C8H10N2 |
Molar mass | 134.182 g·mol−1 |
3D model ( JSmol) | |
|
Phenylethylidenehydrazine (PEH), also known as 2-phenylethylhydrazone or β-phenylethylidenehydrazine, is a GABA transaminase inhibitor. [1] [2] It is a metabolite of the antidepressant phenelzine and is responsible for its elevation of GABA concentrations. [1] PEH may contribute to phenelzine's anxiolytic effects. [3]